PRCT

Neutral

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Average Recommendation of "Hold" from Brokerages

PROCEPT BioRobotics (NASDAQ:PRCT) has received a consensus "Hold" rating from 14 research firms, with an average 1-year price target of $41.45. The co...

MarketBeat 2 days ago 0

Neutral

PROCEPT BioRobotics (NASDAQ: PRCT) Q1 2026 revenue rises 20%

PROCEPT BioRobotics reported a 20% increase in Q1 2026 revenue to $83.1 million, driven by higher system sales, consumables, and services, especially ...

Stock Titan 2 weeks ago 0